← Leaderboards
Stephen Popielarski
Thermaquil, Inc.
$1,114,998
Attributed
$2,229,995
Total exposure
2
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $998.1K · FY2019–22$1M$750K$500K$250K$0
'19
'20
'21
'22
Funding mix
By agency
NIH$2,229,995 · 2
By mechanism
R44$1,675,670 · 1
R41$554,325 · 1
Top collaborators
- Hsiangkuo Yuan2 shared
- Stephen L Meloni1 shared
- Changfeng Tai1 shared
Most similar at Thermaquil, Inc.
Same institution · by research overlap
- Hsiangkuo Yuan$837,835
- Stephen L Meloni$27,500
Others in their field
Other Emerging Leaders on “Opioid Use”
- Chanza Baytop · Westat, Inc.$271,217,917
- Jeffrey Reich · Sparian Biosciences, Inc.$28,894,251
- Andrew S Huhn · Johns Hopkins University$19,514,484
- Emmanuel Aja Oga · Research Triangle Institute$17,470,090
- Suparna Goswami · Univ Of North Carolina Chapel Hill$16,919,767
- Meredith C. B. Adams · Medical College Of Wisconsin$12,691,289
Research focus
Opioid UseTransmission ProcessNerveLiquid SubstancePain SignalPainPharmaceutical PreparationsDesignNerve BlockDevicesBasePain ManagementAmericanPain ReductionDrug UsagePain PatientNeural ConductionNeurologicAftercareMedicalEffectivenessAnalgesicsInterviewMonitor
Grant awards (4)
Drug Free Nerve Block Device for the Relief of Pain and Symptoms in Migraines and other Headaches$677,548
R44 · FY2022 · NS · contact PI
Drug Free Nerve Block Device for the Relief of Pain and Symptoms in Migraines and other Headaches$998,122
R44 · FY2021 · NS · contact PI
Customer discovery for minimally invasive nerve block device to treat severe pain and reduce usage of opiates$55,000
R41 · FY2020 · NS
Minimally Invasive Intercostal Nerve Block Device to Treat Severe Pain and Reduce Usage of Opiates$499,325
R41 · FY2019 · NS